Okada S, Kita H, George T J, Gleich G J, Leiferman K M
Department of Immunology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Am J Respir Cell Mol Biol. 1997 Apr;16(4):455-63. doi: 10.1165/ajrcmb.16.4.9115757.
Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1alpha, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by beta1- and beta2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.
嗜酸性粒细胞穿过基底膜屏障的迁移是其浸润到组织中的重要步骤。为了研究迁移机制,我们使用了一个装有基质胶膜的小室作为基底膜模型。在这个模型中,单独用细胞因子或趋化因子处理的嗜酸性粒细胞不会从上室迁移到下室。然而,血小板活化因子(PAF)强烈诱导白细胞介素(IL)-5刺激的嗜酸性粒细胞迁移,这表明细胞因子和趋化因子对于嗜酸性粒细胞通过基质胶的迁移都是必需的。粒细胞-巨噬细胞集落刺激因子(GM-CSF)和IL-3在PAF存在的情况下也刺激嗜酸性粒细胞迁移。在测试的七种嗜酸性粒细胞趋化因子中,白三烯B4、C5a、RANTES、巨噬细胞炎性蛋白-1α和IL-8没有诱导明显的嗜酸性粒细胞迁移。只有PAF和嗜酸性粒细胞趋化因子在IL-5存在的情况下诱导嗜酸性粒细胞通过基质胶迁移;在最佳浓度下,PAF比嗜酸性粒细胞趋化因子更有效。相比之下,在没有IL-5的情况下,PAF、嗜酸性粒细胞趋化因子和RANTES都能有效诱导嗜酸性粒细胞通过裸膜迁移。最后,抗CD1β和抗CD29单克隆抗体的组合显著减少了嗜酸性粒细胞通过基质胶的迁移,这表明它是由β1和β2整合素粘附分子介导的。我们的研究结果表明,嗜酸性粒细胞通过基底膜模型的迁移需要一种特定的趋化剂,如PAF,以及一种嗜酸性粒细胞活化细胞因子,如IL-5。这种协同效应可能在过敏性和其他嗜酸性粒细胞相关疾病中活化嗜酸性粒细胞的组织积聚中起重要作用。